CEO Roundtable: Biotech leaders enjoy deep interest from investors amid pandemic Technology April 28, 20218:12:38 pm
FDA grants rare disease drug status to AmideBio’s pediatric hyperinsulinism treatment Government & Politics August 20, 20206:52:58 pm
Improving access to capital, talent a priority for Boulder biotech firms Cannabis April 23, 20198:22:30 pm
Diabetes-industry veteran Fludzinski named CEO of AmideBio Health Care & Insurance May 16, 20187:02:24 pm
Boulder’s bioscience industry growing to critical mass Health Care & Insurance April 18, 20189:16:19 pm
AmideBio receives grant to advance work on hyperinsulinism Health Care & Insurance September 27, 20178:19:11 pm
